Lisa Greene
Family · Hildebran, NCNPI 1346811411
Payments from drug & device makers
Across 177 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$656
- AbbVie$387
- Novo Nordisk$376
- GSK$350
- Lilly USA, LLC$245
- Pfizer$182
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,50197%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $656 |
| AbbVie | 24 | $387 |
| Novo Nordisk | 26 | $376 |
| GSK | 13 | $350 |
| Lilly USA, LLC | 13 | $245 |
| Pfizer | 8 | $182 |
| Astellas Pharma US Inc | 5 | $176 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $131 |
| Esperion Therapeutics, Inc. | 7 | $118 |
| Sanofi-aventis U.S. LLC | 4 | $100 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Boehringer Ingelheim | 5 | $92 |
| LKC Technologies, Inc. | 1 | $91 |
| Ironwood Pharmaceuticals, Inc | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 5 | $63 |
| Dexcom, Inc. | 3 | $58 |
| Exact Sciences | 3 | $56 |
| Sanofi Pasteur Inc. | 2 | $47 |
| Viatris Specialty LLC | 2 | $35 |
| Indivior Inc. | 2 | $34 |
| Bayer | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Abbott | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Mylan Specialty L.p. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $20 |
| Corium, LLC | 1 | $18 |
| Braeburn Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Tonix Medicines, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,601 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 61 | $82,710 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $47,657 |
| FarxigaDapagliflozin Propanediol | 29 | $37,925 |
| EliquisApixaban | 27 | $29,861 |
| RybelsusSemaglutide | 14 | $18,783 |
| TradjentaLinagliptin | 27 | $18,595 |
| JanuviaSitagliptin Phosphate | 13 | $17,017 |
| GemtesaVibegron | 12 | $5,489 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 90 | $2,195 |
| Omeprazole | 137 | $2,153 |
| BystolicNebivolol Hcl | 12 | $2,004 |
| Levothyroxine Sodium | 198 | $1,635 |
| Tramadol Hcl | 83 | $1,163 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 52 | $1,064 |
| Pantoprazole Sodium | 105 | $1,015 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $376 | $101,49375 claims |
| GSKTrelegy Ellipta | $350 | $47,65754 claims |
| AstraZenecaFarxiga | $656 | $37,92529 claims |
| PfizerEliquis | $182 | $29,86127 claims |
| Boehringer IngelheimTradjenta | $92 | $18,59527 claims |
| Kowa Pharmaceuticals America, Inc.Bystolic | $13 | $2,00412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.
Other family in Hildebran
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.